Logo image of DSFIR.AS

DSM-FIRMENICH AG (DSFIR.AS) Stock Fundamental Analysis

AMS:DSFIR - CH1216478797 - Common Stock

82.02 EUR
+0.86 (+1.06%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

DSFIR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. DSFIR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, DSFIR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DSFIR had positive earnings in the past year.
DSFIR had a positive operating cash flow in the past year.
DSFIR.AS Yearly Net Income VS EBIT VS OCF VS FCFDSFIR.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

DSFIR has a Return On Assets (0.77%) which is comparable to the rest of the industry.
DSFIR's Return On Equity of 1.17% is in line compared to the rest of the industry. DSFIR outperforms 45.59% of its industry peers.
DSFIR has a worse Return On Invested Capital (1.27%) than 63.24% of its industry peers.
Industry RankSector Rank
ROA 0.77%
ROE 1.17%
ROIC 1.27%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DSFIR.AS Yearly ROA, ROE, ROICDSFIR.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of DSFIR (1.95%) is comparable to the rest of the industry.
DSFIR's Profit Margin has declined in the last couple of years.
The Operating Margin of DSFIR (4.38%) is comparable to the rest of the industry.
DSFIR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 33.17%, DSFIR is in line with its industry, outperforming 50.00% of the companies in the same industry.
DSFIR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.38%
PM (TTM) 1.95%
GM 33.17%
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
DSFIR.AS Yearly Profit, Operating, Gross MarginsDSFIR.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

DSFIR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DSFIR has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, DSFIR has a worse debt to assets ratio.
DSFIR.AS Yearly Shares OutstandingDSFIR.AS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M 250M
DSFIR.AS Yearly Total Debt VS Total AssetsDSFIR.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10B 20B 30B

2.2 Solvency

The Debt to FCF ratio of DSFIR is 7.12, which is on the high side as it means it would take DSFIR, 7.12 years of fcf income to pay off all of its debts.
DSFIR has a Debt to FCF ratio of 7.12. This is in the better half of the industry: DSFIR outperforms 66.18% of its industry peers.
DSFIR has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DSFIR (0.24) is better than 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Altman-Z N/A
ROIC/WACC0.3
WACC4.24%
DSFIR.AS Yearly LT Debt VS Equity VS FCFDSFIR.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 2.69 indicates that DSFIR has no problem at all paying its short term obligations.
DSFIR has a Current ratio of 2.69. This is in the better half of the industry: DSFIR outperforms 77.94% of its industry peers.
A Quick Ratio of 1.74 indicates that DSFIR should not have too much problems paying its short term obligations.
The Quick ratio of DSFIR (1.74) is better than 80.88% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.74
DSFIR.AS Yearly Current Assets VS Current LiabilitesDSFIR.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

DSFIR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.70%.
The earnings per share for DSFIR have been decreasing by -45.42% on average. This is quite bad
Looking at the last year, DSFIR shows a very strong growth in Revenue. The Revenue has grown by 20.44%.
Measured over the past years, DSFIR shows a small growth in Revenue. The Revenue has been growing by 3.80% on average per year.
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%0.28%

3.2 Future

The Earnings Per Share is expected to grow by 11.12% on average over the next years. This is quite good.
DSFIR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.84% yearly.
EPS Next Y24.72%
EPS Next 2Y14.83%
EPS Next 3Y14.31%
EPS Next 5Y11.12%
Revenue Next Year0.77%
Revenue Next 2Y1.68%
Revenue Next 3Y2.84%
Revenue Next 5Y2.84%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DSFIR.AS Yearly Revenue VS EstimatesDSFIR.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
DSFIR.AS Yearly EPS VS EstimatesDSFIR.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 87.26 indicates a quite expensive valuation of DSFIR.
DSFIR's Price/Earnings ratio is a bit more expensive when compared to the industry. DSFIR is more expensive than 60.29% of the companies in the same industry.
DSFIR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.06.
The Price/Forward Earnings ratio is 19.15, which indicates a rather expensive current valuation of DSFIR.
DSFIR's Price/Forward Earnings ratio is in line with the industry average.
DSFIR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 87.26
Fwd PE 19.15
DSFIR.AS Price Earnings VS Forward Price EarningsDSFIR.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

DSFIR's Enterprise Value to EBITDA is on the same level as the industry average.
63.24% of the companies in the same industry are more expensive than DSFIR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.6
EV/EBITDA 12.67
DSFIR.AS Per share dataDSFIR.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DSFIR's earnings are expected to grow with 14.31% in the coming years.
PEG (NY)3.53
PEG (5Y)N/A
EPS Next 2Y14.83%
EPS Next 3Y14.31%

More info and screens

3

5. Dividend

5.1 Amount

DSFIR has a Yearly Dividend Yield of 3.08%.
DSFIR's Dividend Yield is a higher than the industry average which is at 3.08.
Compared to an average S&P500 Dividend Yield of 2.32, DSFIR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.08%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DSFIR.AS Yearly Dividends per shareDSFIR.AS Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2

5.3 Sustainability

286.40% of the earnings are spent on dividend by DSFIR. This is not a sustainable payout ratio.
DP286.4%
EPS Next 2Y14.83%
EPS Next 3Y14.31%
DSFIR.AS Yearly Income VS Free CF VS DividendDSFIR.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 500M 1B 1.5B 2B
DSFIR.AS Dividend Payout.DSFIR.AS Dividend Payout, showing the Payout Ratio.DSFIR.AS Dividend Payout.PayoutRetained Earnings

More info and screens

DSM-FIRMENICH AG

AMS:DSFIR (9/5/2025, 7:00:00 PM)

82.02

+0.86 (+1.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-30 2025-10-30
Inst Owners25.14%
Inst Owner ChangeN/A
Ins Owners9.64%
Ins Owner ChangeN/A
Market Cap21.79B
Analysts80.67
Price Target122.83 (49.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.08%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP286.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-3.56%
Max Revenue beat(2)-3.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.4%
Min Revenue beat(4)-4.12%
Max Revenue beat(4)-2.47%
Revenue beat(8)1
Avg Revenue beat(8)-2.68%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.32%
PT rev (3m)-3.98%
EPS NQ rev (1m)2.8%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.46%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.85%
Valuation
Industry RankSector Rank
PE 87.26
Fwd PE 19.15
P/S 1.7
P/FCF 28.6
P/OCF 13.71
P/B 1.02
P/tB 4.55
EV/EBITDA 12.67
EPS(TTM)0.94
EY1.15%
EPS(NY)4.28
Fwd EY5.22%
FCF(TTM)2.87
FCFY3.5%
OCF(TTM)5.98
OCFY7.3%
SpS48.17
BVpS80.37
TBVpS18.03
PEG (NY)3.53
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.17%
ROCE 1.94%
ROIC 1.27%
ROICexc 1.41%
ROICexgc 3.87%
OM 4.38%
PM (TTM) 1.95%
GM 33.17%
FCFM 5.95%
ROA(3y)5.56%
ROA(5y)N/A
ROE(3y)8.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.02%
OM growth 5YN/A
PM growth 3Y-36.48%
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5YN/A
F-Score7
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Debt/EBITDA 2.72
Cap/Depr 61.7%
Cap/Sales 6.47%
Interest Coverage 7.37
Cash Conversion 83.6%
Profit Quality 304.8%
Current Ratio 2.69
Quick Ratio 1.74
Altman-Z N/A
F-Score7
WACC4.24%
ROIC/WACC0.3
Cap/Depr(3y)68.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.69%
Cap/Sales(5y)N/A
Profit Quality(3y)150.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.7%
EPS 3Y-45.42%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y24.72%
EPS Next 2Y14.83%
EPS Next 3Y14.31%
EPS Next 5Y11.12%
Revenue 1Y (TTM)20.44%
Revenue growth 3Y3.8%
Revenue growth 5YN/A
Sales Q2Q%0.28%
Revenue Next Year0.77%
Revenue Next 2Y1.68%
Revenue Next 3Y2.84%
Revenue Next 5Y2.84%
EBIT growth 1Y226.7%
EBIT growth 3Y-11.79%
EBIT growth 5YN/A
EBIT Next Year140.16%
EBIT Next 3Y38.54%
EBIT Next 5Y23.51%
FCF growth 1Y160.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.8%
OCF growth 3YN/A
OCF growth 5YN/A